We are looking for a Senior Account Executive to join our Sales team at BenchSci reporting to the CCO Chief Commercial Officer, where you will play a pivotal role in driving revenue growth by acquiring, retaining, and expanding relationships with high-value customers in the pharmaceutical and life sciences sectors, focusing on complex, enterprise-level accounts while serving as a strategic advisor to both clients and internal teams.
You Will:Lead high-value acquisition, negotiation, retention, and expansion efforts with a focus on enterprise-level accounts in the pharmaceutical and life sciences industries.
Identify and evaluate strategic opportunities, guiding the sales team in effective lead generation and account targeting.
Develop and execute quarterly account plans to align client needs with company objectives, ensuring measurable outcomes.
Collaborate with Scientific Experts to deliver customized presentations and product demonstrations that address specific client challenges.
Oversee all stages of the sales process, from prospecting to contract execution, ensuring efficiency and delivering exceptional outcomes.
Maintain accurate, up-to-date CRM data and ensure adherence to sales best practices across the team.
Provide timely updates on deal progress, pipeline growth, and revenue forecasting through CRM reports and executive summaries.
Work closely with GTM (Go-To-Market) teams and other departments to develop innovative strategies that drive client success and account growth.
Share expertise and mentor junior team members, fostering a collaborative and high-performing sales culture.
5+ years of demonstrated success in SaaS or pharmaceutical/life sciences sales, with experience managing complex or enterprise-level accounts.
Advanced knowledge of SalesForce, HubSpot, and GSuite, with the ability to optimize account management and pipeline processes.
Exceptional written and verbal communication skills, with expertise in crafting compelling presentations and negotiating high-value deals.
Strong analytical skills with the ability to develop creative, data-driven solutions to complex challenges.
Proven ability to build and sustain long-term relationships with senior-level stakeholders and decision-makers.
Experience mentoring and guiding team members, contributing to their professional development and overall team success.
A commitment to continuous learning and the ability to thrive in a fast-paced, dynamic environment.
Highly organized and focused on achieving measurable outcomes, with a track record of consistently exceeding sales targets.
Compensation:
$120,000- $160,000 USD • includes equity options
We know compensation is an important part of choosing your next role. The range shown reflects our target hiring range, informed by market data, internal equity, and the role's current scope. Often the mid-range is where we tend to fall, but individual offers may vary based on experience, skills, and the role scope.
BenchSci's mission is to unravel the complexity of disease biology for the betterment of patients. We do this by applying neuro-symbolic AI to unravel the black box of disease biology — the number one reason drug discovery projects fail.
Despite significant advancements, drug discovery still takes over a decade and billions of dollars — and 90% of clinical trials still fail. The core problem is getting the biology wrong before programs go to scale. BenchSci exists to fix that.
Our platform, ASCEND, is the world's first neuro-symbolic AI built for biopharma disease biology. It gives scientists clarity in hours or weeks that previously took months. Our platform is used by 9 of the top 10 pharmaceutical companies across 4,500+ research centers, and grew 247% over three years (Deloitte Fast 500, 2025). We've raised $200M+ from Generation Investment Management, Google's Gradient Ventures, TCV, and F-Prime.
Top Skills
Similar Jobs
What you need to know about the NYC Tech Scene
Key Facts About NYC Tech
- Number of Tech Workers: 549,200; 6% of overall workforce (2024 CompTIA survey)
- Major Tech Employers: Capgemini, Bloomberg, IBM, Spotify
- Key Industries: Artificial intelligence, Fintech
- Funding Landscape: $25.5 billion in venture capital funding in 2024 (Pitchbook)
- Notable Investors: Greycroft, Thrive Capital, Union Square Ventures, FirstMark Capital, Tiger Global Management, Tribeca Venture Partners, Insight Partners, Two Sigma Ventures
- Research Centers and Universities: Columbia University, New York University, Fordham University, CUNY, AI Now Institute, Flatiron Institute, C.N. Yang Institute for Theoretical Physics, NASA Space Radiation Laboratory



